Calcium-independent phospholipase A2β (iPLA2β)-mediated lipid peroxidation detoxification is sufficient to inhibit p53-driven ferroptosis under ROS-induced stress and acts as a major ferroptosis suppressor independent of GPX4, suggesting that iPLA2β is a promising therapeutic tumor target (68). Here, TP53 is linked to neoplasm.